Sakharnyy diabet i gormonal'naya enterologiya: put' v prekrasnoe daleko?
The gastrointestinal tract produces hormones that influence glucose-induced pancreatic insulin secretion. One of them is glucagon-like peptide 1.Its synthetic analog, liraglutide, has properties that promote metabolic control in patients with type 2 diabetes mellitus and have beneficial effecton the...
Saved in:
Main Author: | Andrey Alexeevich Aleksandrov |
---|---|
Format: | article |
Language: | EN RU |
Published: |
Endocrinology Research Centre
2011
|
Subjects: | |
Online Access: | https://doaj.org/article/ff15bb33442a4c7ebf456e58eb7f3b93 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The associations of incretin hormone concentration with gestational diabetes mellitus
by: Tatiana V. Saprina, et al.
Published: (2016) -
Incretins today: multiple effects and therapeutic potential
by: Oksana V. Tsygankova, et al.
Published: (2019) -
Pharmalogical effects and results of clinical trials of the first incretinomimetic exenatide
by: Alexander Sergeevich Ametov, et al.
Published: (2011) -
Zamestitel'naya gormonal'naya terapiya i techenie distal'noy diabeticheskoy polineyropatii u zhenshchin v postmenopauze
by: T A Zelenina, et al.
Published: (2007) -
Evolution of glucagon-like peptide-1 receptor agonists for the treatment of type 2 diabetes
by: Gagik R. Galstyan, et al.
Published: (2017)